TITLE

PreViser inks Japanese marketing agreement

PUB. DATE
March 2006
SOURCE
Proofs;Mar2006, Vol. 89 Issue 2, p59
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
Reports on the licensing agreement between PreViser Corp., a provider of patented oral disease and risk assessment software technology, and OralCare Corp. to market PreViser technology to dentists within Japan. Terms of the agreement; Number of Japanese dentists who are currently customers for the preventive dentistry products of OralCare; Significance of the transaction to OralCare.
ACCESSION #
20520030

 

Related Articles

  • Free trial of risk assessment software.  // British Dental Journal;6/14/2008, Vol. 204 Issue 11, p649 

    This article reports on the release of Previser Corp.'s PreViser software for dentistry in Great Britain's dental industry. This release takes place after a licensing agreement was reached with Oral Health Innovations. The software should help with oral health risk assessments. Free downloads of...

  • Horizon League inks first licensing deal. Schoettle, Anthony // Indianapolis Business Journal;9/8/2003, Vol. 24 Issue 26, p3A 

    Reports on the three-year licensing and promotion deal signed by Indianapolis, Indiana-based basketball collegiate league Horizon League with West Lafayette, Indiana-based Strategic Marketing Affiliates. Terms and conditions of the deal; Impact of the deal on athlete recruitment and revenue...

  • A Primer on Licensing --Yes, Both Kinds. Reily, Stephen // Brandweek;6/11/2007, Vol. 48 Issue 24, p16 

    The article provides an overview of licensing terminology and distinctions in the U.S. advertising and marketing industry. Anticipation for the yearly licensing industry meeting in New York City in June 2007 is mentioned. The differences between the two examples of brand extension and brand...

  • Adler Inks Stacy Adams License. Tschorn, Adam // DNR: Daily News Record;1/10/2005, Vol. 35 Issue 2, p6 

    Deals with the license given to Adler Sportswear by Weyco Group to manufacture and market men's leather apparel under the Stacy Adams label. Coverage of the license; Forecast on the result of the licensing agreement for Adler; factor that influenced Adler to venture in licensing agreements.

  • Small Bone Innovations rolls up its accords with Artimplant.  // Medical Device Daily;2/10/2009, Vol. 13 Issue 26, p3 

    This article reports on the move by Small Bone Innovations, a biotechnology company based in New York, to consolidate five separate agreements into a single new agreement on worldwide license, supply and distribution of Artelon products with Artimplant of Vastra Frolunda, Sweden. The...

  • Deals Roundup.  // BioWorld Today;8/26/2008, Vol. 19 Issue 166, p4 

    The article reports that Generex Biotechnology Corp. and Dong-Sung Pharm Co. Ltd. of South Korea entered into a licensing and distribution agreement. Under the deal, Dong-Sung will market and distribute Generex Oral-lyn, an oral insulin spray product. Dong-Sung will pay nonrefundable, up-front...

  • Theratechnologies Inks $215M Tesamorelin Deal with Serono. Morrison, Trista // BioWorld Today;10/30/2008, Vol. 19 Issue 212, p1 

    The article reports on a potential $215 million marketing deal signed by Theratechnologies Inc. with Merck KGaA affiliate EMD Serono Inc. Under the deal, Merck will pay Theratechnologies $30 million up front, consisting of a $22 million licensing fee and an $8 million equity investment by Merck....

  • Asplundh Brings e-Vegetation Management Solution to Market.  // Utility Automation & Engineering T&D;Jul/Aug2006, Vol. 11 Issue 6, p16 

    The article reports on the license and distribution agreement signed by Asplundh Tree Expert Co. for the marketing of its electronic vegetation management solution (eVMS) in North America, Great Britain, Australia, and New Zealand. The eVMS permits utilities to develop, plan, execute, monitor,...

  • VALEANT MARKETS LESCARDEN'S CATRIX7 WOUND DRESSING.  // Worldwide Biotech;Nov2004, Vol. 16 Issue 11, p7 

    Reports on a license agreement between Lescarden Inc. and Valeant Pharmaceuticals International that grants Valeant an exclusive license to market Lescarden's proprietary product throughout Europe. Information on Lescarden's Catrix7 Wound Dressing; Implication of the agreement for the...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics